147 related articles for article (PubMed ID: 15208000)
21. Desmopressin stimulates parallel norepinephrine and tissue plasminogen activator release in normal subjects and patients with diabetes mellitus.
Grant MB; Guay C; Lottenberg R
Thromb Haemost; 1988 Apr; 59(2):269-72. PubMed ID: 3133810
[TBL] [Abstract][Full Text] [Related]
22. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma.
Huisman LG; van Griensven JM; Kluft C
Thromb Haemost; 1995 Mar; 73(3):466-71. PubMed ID: 7667830
[TBL] [Abstract][Full Text] [Related]
23. The physiology of deep-water running.
Reilly T; Dowzer CN; Cable NT
J Sports Sci; 2003 Dec; 21(12):959-72. PubMed ID: 14748454
[TBL] [Abstract][Full Text] [Related]
24. Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection.
Chang LC; Meyerhoff ME; Yang VC
Anal Biochem; 1999 Dec; 276(1):8-12. PubMed ID: 10585738
[TBL] [Abstract][Full Text] [Related]
25. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
[TBL] [Abstract][Full Text] [Related]
26. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
[TBL] [Abstract][Full Text] [Related]
27. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
Piedagnel R; Tiger Y; Lelongt B; Ronco PM
J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905
[TBL] [Abstract][Full Text] [Related]
28. Maximal metabolic responses of deep and shallow water running in trained runners.
Town GP; Bradley SS
Med Sci Sports Exerc; 1991 Feb; 23(2):238-41. PubMed ID: 2017021
[TBL] [Abstract][Full Text] [Related]
29. Genetic markers of fibrinolytic responses of older persons to exercise training.
Kulaputana O; Ghiu I; Phares DA; Ferrell RE; Macko RF; Goldberg AP; Hagberg JM
Int J Sports Med; 2006 Aug; 27(8):617-22. PubMed ID: 16874588
[TBL] [Abstract][Full Text] [Related]
30. Induction of fibronectin mRNA by urokinase- and tissue-type plasminogen activator in human skin fibroblasts: differential role of u-PA and t-PA at the fibronectin protein level.
De Petro G; Tavian D; Marchina E; Barlati S
Biol Chem; 2002 Jan; 383(1):177-87. PubMed ID: 11928812
[TBL] [Abstract][Full Text] [Related]
31. Influence of low- and high-molecular-weight plasminogen activators on the onset of labor and on the hemostatic system.
Moriyama T; Suzuki S; Matsuno K; Okada K; Matsuo O
Semin Thromb Hemost; 2002 Dec; 28(6):529-32. PubMed ID: 12536345
[TBL] [Abstract][Full Text] [Related]
32. Plasminogen activator system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
[TBL] [Abstract][Full Text] [Related]
33. Growth factors, tissue and urokinase-type plasminogen activators in venous ulcers.
Lagattolla NR; Stacey MC; Burnand KG; Gaffney PG
Ann Cardiol Angeiol (Paris); 1995; 44(6):299-303. PubMed ID: 7574362
[TBL] [Abstract][Full Text] [Related]
34. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
[TBL] [Abstract][Full Text] [Related]
35. Plasminogen activators and their inhibitors in leukemic cell homogenates.
Wada H; Kumeda Y; Ogasawara Z; Ohiwa M; Kaneko T; Tamaki S; Ohno T; Kageyama S; Kobayashi T; Deguchi K
Am J Hematol; 1993 Feb; 42(2):166-70. PubMed ID: 8438877
[TBL] [Abstract][Full Text] [Related]
36. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
[TBL] [Abstract][Full Text] [Related]
37. Involvement of plasminogen activator and plasminogen activator inhibitor type 1 in spermatogenesis, sperm capacitation, and fertilization.
Liu YX
Semin Thromb Hemost; 2007 Feb; 33(1):29-40. PubMed ID: 17253187
[TBL] [Abstract][Full Text] [Related]
38. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
39. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
40. Increased urokinase-type plasminogen activator (u-PA) levels in graft liver perfusate and decreased single chain u-PA activation with higher levels of aprotinin.
Himmelreich G; Dooijewaard G; Neuhaus P; Kluft C; Bechstein WO; Riess H
Thromb Haemost; 1994 Jan; 71(1):12-4. PubMed ID: 7513093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]